Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (KCT0012631) titled 'A prospective randomised trial on the omission of axillary lymph node dissection in ultrasound-detectable axillary meastases in primary breast cancer treated by upfront surgery' on Sept. 16.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

Primary Sponsor: Samsung Medical Center

Condition:

Neoplasms

Intervention: Procedure/Surgery : Participants will be randomly assigned to either the intervention group (upfront Targeted Axillary Dissection, TAD) or the control group (upfront Axillary Lymph Node Dissection, ALND...